Navigation Links
Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil

INDIANAPOLIS and SAO PAULO, Brazil, Jan. 28 /PRNewswire-FirstCall/ -- The Brazilian Ministry of Agriculture has authorized Dow AgroSciences to sell its first corn hybrids with HERCULEX(R) I Insect Protection technology. This authorization was given for 2B710HX, 2B688HX, 2B707HX, 2C520HX and 2A525HX corn hybrids. Dow AgroSciences also announced that it plans to be able to offer the Brazilian market its full range of corn hybrids with this technology in the future.

"This is a key milestone that will make available the best corn seed technology to the Brazilian producer and will set a new standard for insect protection in Brazil," said Jerome Peribere, president and CEO, Dow AgroSciences.

HERCULEX I, approved in Brazil in December 2008 by the National Technical Commission of Biosafety (CTNBio), has been in use in the United States, Argentina and other countries for a number of years. The technology provides effective control of important corn pests by incorporating into the plant the cry1F gene, originated from the Bacillus thuringiensis (Bt) microorganism that naturally occurs in the soil.

HERCULEX I protects the corn plant against the Spodoptora frugiperda caterpillar, the main corn pest in Brazil. This protection is extended to the entire life cycle of the plant. It also allows the control of Diatraea saccharalis. Depending upon growing conditions, these pests may cause yield losses of more 40 percent.

With this technology, Brazilian growers should benefit with higher yield, better quality grain, and a new and effective tool to use as part of an integrated pest management system.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at

(R)HERCULEX is a trademark of Dow AgroSciences LLC

HERCULEX Insect Protection technology developed by Dow AgroSciences and Pioneer Hi-Bred International

SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Dow AgroSciences Success Presented to Wall Street
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
4. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
Breaking Biology Technology:
(Date:10/27/2015)... Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ... so that they can be quantitatively analyzed with SMI,s ... Germany , October 28-29, 2015. SMI,s Automated Semantic ... eye tracking videos created with SMI,s Eye Tracking ...
(Date:10/26/2015)... Calif. and LAS VEGAS ... Nok Nok Labs , an innovator in modern authentication ... , today announced the launch of its latest version ... unified platform enabling organizations to use standards-based authentication that ... Nok Nok S3 Authentication Suite is ideal for organizations ...
(Date:10/23/2015)... and GOLETA, California , October ... conference, BIOPAC and SensoMotoric Instruments (SMI) announce a mobile ... tracking data captured during interactive real-world tasks ... play integration of their established wearable solutions for eye ... synchronize gaze behavior captured with SMI Eye Tracking ...
Breaking Biology News(10 mins):